Immunotherapy Combo Treats Advanced Kidney Cancer
First results show survival benefit with nivolumab plus cabozantinib versus sunitinib
Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death
Risk for dying from breast cancer remains elevated 15 years after initial diagnosis
Antibodies Decrease With Time After COVID-19 Symptom Onset
For all donors of convalescent plasma, drop seen in anti-RBD antibody levels from first to last donation
Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression
Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression
HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
Incidence rate ratio 0.12 among women vaccinated before age 17; 0.47 for those vaccinated at ages 17 to 30
September 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2020. This roundup includes...
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
From February to April 2020, drop >20 percent observed for all primary admission diagnoses
Review IDs Dietary Factors Linked to Lower CRC Incidence
Incidence up with frequent alcohol or meat consumption; no evidence of protective effect found for tea, coffee
Cancer Mortality Higher for U.S. Counties With Persistent Poverty
Counties with persistent poverty have higher overall, several type-specific cancer mortality rates
High-Risk Patients Not Aware of Needed Colonoscopy Intervals
Findings among patients with biopsy-confirmed advanced colorectal polyps
